Package Leaflet: Information for the Patient
Wegovy 0.25mg FlexTouch solution for injection in pre-filled pen
Wegovy 0.5mg FlexTouch solution for injection in pre-filled pen
Wegovy 1mg FlexTouch solution for injection in pre-filled pen
Wegovy 1.7mg FlexTouch solution for injection in pre-filled pen
Wegovy 2.4mg FlexTouch solution for injection in pre-filled pen
semaglutide
This medicine is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the pack
What is Wegovy
Wegovy is a medicine for weight loss and weight maintenance that contains the active substance semaglutide. It is similar to a naturally occurring hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after eating. It works by acting on areas (receptors) of the brain that control appetite, making you feel fuller and less hungry, and experiencing less desire to eat. This will help you eat fewer calories and reduce body weight. Wegovy may also help prevent heart disease.
What Wegovy is used for
Wegovy is used together with diet and physical activity to lose weight and help keep weight under control. It is used in adults who have
Body Mass Index (BMI) is a measure of weight in relation to height.
Wegovy is used together with diet and physical activity for weight control in adolescents aged 12 years and older with
As an adolescent patient, you should only continue using Wegovy if you have lost at least 5% of your BMI after 12 weeks of treatment with the 2.4 mg dose or the maximum tolerated dose (see section 3). Consult your doctor before continuing.
Do not use Wegovy
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start using Wegovy.
Wegovy should not be used if:
There is limited experience with Wegovy in patients:
Talk to your doctor if you are in any of these situations.
If you know you are going to have surgery where you will be under anesthesia (sleep), tell your doctor that you are taking Wegovy.
During treatment with Wegovy, you may have nausea, vomiting, or diarrhea. These side effects can cause dehydration (loss of fluids). It is important to drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. If you have any doubts or concerns, talk to your doctor.
If you have severe and persistent stomach pain (see section 4), go to the doctor immediately, as it could be a symptom of pancreatitis (acute pancreatitis).
Wegovy cannot be used as a substitute for insulin. Do not use Wegovy in combination with other medicines that contain GLP-1 receptor agonists (such as liraglutide, dulaglutide, exenatide, or lixisenatide).
Taking a sulfonylurea or insulin with Wegovy may increase the risk of experiencing low blood sugar (hypoglycemia). To know the warning signs of low blood sugar, see section 4. Your doctor may ask you to measure your blood sugar levels. This will help your doctor decide if it is necessary to change the dose of sulfonylurea or insulin to reduce the risk of low blood sugar.
If you have diabetic eye disease and are using insulin, this medicine may cause your vision to worsen and you may need treatment. Sudden improvements in blood sugar control can cause a temporary worsening of diabetic eye disease. Tell your doctor if you have diabetic eye disease and experience eye problems while taking this medicine.
Children and adolescents
The safety and efficacy of Wegovy in children under 12 years of age have not been studied, and its use is not recommended in this population.
Other medicines and Wegovy
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines.
In particular, tell your doctor, pharmacist, or nurse if you are using medicines that contain:
Pregnancy and breastfeeding
This medicine should not be used during pregnancy, as it is not known if it can affect the fetus. Therefore, it is recommended to use contraceptive methods during the use of this medicine. If you wish to become pregnant, you should stop using this medicine at least 2 months in advance. If you become pregnant, think you may be pregnant, or plan to become pregnant while using this medicine, talk to your doctor immediately, as you should stop treatment.
Do not use this medicine during breastfeeding, as it is not known if it is excreted in breast milk.
Driving and using machines
Wegovy is unlikely to affect your ability to drive or use machines. Some patients may feel dizzy when using Wegovy, mainly during the first 4 months of treatment (see section 4). If you feel dizzy, be extra careful when driving or using machines. If you need more information, talk to your doctor, pharmacist, or nurse.
People with type 2 diabetes
If you use this medicine in combination with a sulfonylurea or insulin, you may experience low blood sugar (hypoglycemia), which can reduce your ability to concentrate. Avoid driving or using machines if you experience any symptoms of low blood sugar. See section 2, "Warnings and precautions" for information on the increased risk of low blood sugar and section 4 to know the warning signs of low blood sugar. For more information, talk to your doctor.
Wegovy contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially "sodium-free".
Follow the instructions for administration given by your doctor exactly. If you are in doubt, talk to your doctor, pharmacist, or nurse again.
How much to use
Adults
The recommended dose is 2.4 mg once a week.
Treatment will start with a low dose that will be gradually increased over 16 weeks of treatment.
Normally, you will be told to follow the following table.
Dose escalation | Weekly dose |
Week 1 to 4 | 0.25 mg |
Week 5 to 8 | 0.5 mg |
Week 9 to 12 | 1 mg |
Week 13 to 16 | 1.7 mg |
From week 17 | 2.4 mg |
Your doctor will regularly assess your treatment.
Adolescents (12 years and older)
For adolescents, the same dose escalation schedule should be applied as for adults (see above). The dose should be increased to 2.4 mg (maintenance dose) or to the maximum tolerated dose. Weekly doses above 2.4 mg are not recommended.
How to administer Wegovy
Wegovy is administered as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle.
On the other side of this leaflet, you will find detailed instructions on how to use the pen.
People with type 2 diabetes
Tell your doctor if you have type 2 diabetes. Your doctor may adjust the dose of your diabetes medication to avoid low blood sugar.
When to use Wegovy
If necessary, you can change the day of the weekly injection of this medicine, as long as at least 3 days have passed since the last injection. Once you have selected a new injection day, you should continue with the weekly dosing schedule.
If you use more Wegovy than you should
Talk to your doctor immediately. You may experience side effects such as nausea, vomiting, or diarrhea, which can cause dehydration (loss of fluids).
If you forget to use Wegovy
If you forget to inject a dose and:
Do not give a double dose to make up for forgotten doses.
If you stop using Wegovy
Do not stop using this medicine without talking to your doctor.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from the available data)
Other side effects
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
The warning signs of low blood sugar may appear suddenly. They can include cold sweat, pale and cold skin, headache, rapid heartbeat, nausea, or excessive hunger, changes in vision, drowsiness, or feeling weak, nervousness, anxiety, or confusion, difficulty concentrating, or tremors.
Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs.
It is more likely that your blood sugar will be low if you are also using a sulfonylurea or insulin. Your doctor may reduce the dose of these medicines before you start using this medicine.
Uncommon(may affect up to 1 in 100 people)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the pen and on the carton after "EXP". The expiry date is the last day of the month stated.
Before opening
Store in a refrigerator (between 2°C and 8°C). Do not freeze. Keep away from the cooling element of the refrigerator.
During use
Do not use this medicine if you notice that the solution is not clear and colorless.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Wegovy
Wegovy 0.25 mg FlexTouch injectable solution
Each pre-filled pen contains 1 mg of semaglutide in 1.5 ml (0.68 mg/ml).
Wegovy 0.5 mg FlexTouch injectable solution
1.5 ml: each pre-filled pen contains 2 mg of semaglutide in 1.5 ml (1.34 mg/ml).
3 ml: each pre-filled pen contains 2 mg of semaglutide in 3 ml (0.68 mg/ml).
Wegovy 1 mg FlexTouch injectable solution
Each pre-filled pen contains 4 mg of semaglutide in 3 ml (1.34 mg/ml).
Wegovy 1.7 mg FlexTouch injectable solution
Each pre-filled pen contains 6.8 mg of semaglutide in 3 ml (2.27 mg/ml).
Wegovy 2.4 mg FlexTouch injectable solution
Each pre-filled pen contains 9.6 mg of semaglutide in 3 ml (3.2 mg/ml).
Appearance of Wegovy and Container Contents
Wegovy is a clear and colorless injectable solution in a pre-filled pen.
Each pre-filled pen contains 4 doses.
Wegovy 0.25, 0.5, 1, and 1.7 mg FlexTouch injectable solution is available in the following package size:
1 pre-filled pen and 4 NovoFine Plus disposable needles.
Wegovy 2.4 mg FlexTouch injectable solution is available in the following package sizes:
1 pre-filled pen and 4 NovoFine Plus disposable needles.
3 pre-filled pens and 12 NovoFine Plus disposable needles
Not all package sizes may be marketed.
Marketing Authorization Holder
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd
Denmark
Manufacturer
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd
Denmark
Novo Nordisk Production SAS
45, Avenue d’Orléans
28000 Chartres
France
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.
Instructions for Using the Wegovy Pen | |
Read these Instructions Carefullybefore starting to use your Wegovy FlexTouch pen weekly and consult your doctor, nurse, or pharmacist on how to inject Wegovy correctly. The Wegovy pen is a dosing pen that contains your four prescribed doses of Wegovy, corresponding to the four weekly administrations. Use the table found inside the outer packaging cover to keep track of how many injections you have used and how many doses are left in the pen. Wegovy comes in five different pens, each containing one of the following prescribed doses of semaglutide: Always Check the Pen Labelto ensure it contains the prescribed dose of Wegovy. Your pen is designed to be used with 30G, 31G, and 32G disposable needles up to 8 mm in length. The Package Contains:
| |
1 Prepare the Pen with a New Needle | |
Check the Name and Concentrationof your pen to ensure it contains the prescribed dose of Wegovy. Remove the Pen Cap. (See Figure A). | |
Check that the Solution in Your Pen is Clear and Colorless. Look through the pen window. If Wegovy appears cloudy or discolored, do not use the pen. (See Figure B). | |
Always Use a New Needle for Each Injection. Take a Needlewhen you are ready to give the injection. Check that the paper tab and the outer cap of the needle are not damaged, which could affect sterility. If you find any damage, use a new needle. Remove the Paper Tab. (See Figure C). | |
Place the Needle Straight onto the Pen. Screw it on until it is Secure. (See Figure D). | |
The Needle is Covered by Two Caps. You Must Remove Both Caps. If you forget to remove both caps, you will not inject Wegovy. Remove the Outer Needle Cap and Set it Aside.You will need it later to safely remove the needle from the pen. Remove the Inner Needle Cap and Discard it.A drop of Wegovy may appear at the tip of the needle. You should continue to check the flow of Wegovy if you are using a new pen for the first time. See “Check the Flow with Each New Pen”. Never use a bent or damaged needle. For more information on handling needles, see the section “About Needles”that follows these instructions. (See Figure E). | |
Check the Flow with Each New Pen | |
If your Wegovy pen is already in use, go to “2 Selecting the Dose”. Check the flow of Wegovy only before the first injection with each new pen. Turn the dose selector until you see the flow check symbol () (See Figure F). | |
Make sure the flow check symbol matches the dose indicator. (See Figure G). | |
Check the Flow | |
Hold the pen with the needle pointing upwards. Press and Hold the Dose Buttonuntil the dose counter returns to . The must match the dose indicator. A drop of Wegovy should appear at the tip of the needle. This drop indicates that the pen is ready for use. If a drop does not appear, check the flow again. This should only be done twice. If a drop still does not appear, change the needle and check the flow again. Do Not Use the Penif a drop of Wegovy still does not appear. (See Figure H). | |
2 Selecting the Dose | |
Turn the dose selector until the dose counter stopsand shows the selected dose. (See Figure I). | |
The dashed line () on the dose counter will guide you to your dose. The dose selector clicks differently when turned forward, backward, or when passing the dose. You will hear a “click” each time you turn the dose selector. Do not count the pen clicks. (See Figure J). | |
When the Selected Dose Matches the Dose Indicator, You Have Selected the Dose.In this image, the dose is shown as an example. If the dose counter stops before reaching the prescribed dose, see the section “Do You Have Enough Wegovy?”that follows these instructions. (See Figure K). | |
Choose the Injection Site Choose the upper arm, upper thigh, or stomach (keeping a distance of 5 cm from the navel). You can inject in the same body area each week, but make sure it is not in the same spot you used last time. | |
3 Injecting the Dose | |
Insert the Needle Under the Skin. Make Sure You Can See the Dose Counter.Do not touch the dose counter with your fingers. This could interrupt the injection. (See Figure L). | |
Press and Hold the Dose Buttonuntil appears on the dose counter. (See Figure M). Press and Hold the Dose Buttonwith the needle under the skin and count slowly to 6. The must match the dose indicator. You may hear or feel a click when the dose counter returns to . (See Figure N). | |
Remove the Needle from the Skin.If the needle is removed too early, a jet of Wegovy may come out of the needle tip, and the full dose may not be administered. If blood appears at the injection site, press the area lightly to stop the bleeding. You may see a drop of Wegovy on the needle tip after the injection. This is normal and does not affect the dose. (See Figure O). | |
4 After the Injection | |
Insert the Needle Tip into the Outer Needle Capon a flat surface without touching the needle or the outer needle cap. When the Needle is Covered,carefully press the outer needle cap fully. (See Figure P). | |
Unscrew the Needleand carefully dispose of it according to the doctor's, nurse's, pharmacist's, or local authorities' instructions. Never Attempt to Put the Inner Needle Cap Back On,as you could prick yourself with it. Always Dispose of the Needle Immediately After Each Injectionto avoid needle obstruction, contamination, infection, and incorrect dosing. Never Store the Pen with the Needle Attached. (See Figure Q). | |
Put the Pen Cap Back Onafter each use to protect Wegovy from light. (See Figure R). | |
When the pen is empty, dispose of it without a needle, following the doctor's, nurse's, pharmacist's, or local authorities' instructions. The pen cap and empty box can be discarded in household trash. | |
About Needles | |
How to Identify a Blocked or Damaged Needle
How to Proceed with a Blocked Needle
| |
Maintenance of the Pen | |
Treat your pen with care. Rough handling or misuse can cause inaccurate dosing. If this happens, you may not get the desired effect of Wegovy.
| |
Do You Have Enough Wegovy? | |
If the dose counter stops before reaching the prescribed dose, there is not enough Wegovy for a full dose. Discard the pen and use a new Wegovy pen. | |
Important Information | |
|